ChemComm
Page 4 of 5
OMe
+
5
For some selected examples, see: (a) T. C. Fessard, S. P. Andrews, H.
Motoyoshi and E. R. Carreira, Angew. Chem. Int. Ed., 2007, 46,
5g
1)
(10 mol%)
Me
OMe
R
p-NO2C6H4CO2H
CHCl3, temp
Me
NBz
Ph
N
iPr
DOI: 10.1039/C5CC03345D
and R. Xu, J. Am. Chem. Soc. 2007, 129, 10029; (c) M. Rueping, B.
50
55
60
65
70
75
2) 48% HBr (aq)
MeOH, rt
O
N
OH
J. Nachtsheim, S. A. Moreth and M. Bolte, Angew. Chem. Int. Ed.,
2008, 47, 593; (d) J. Itoh, K. Fuchibe and T. Akiyama, Angew.
Chem. Int. Ed., 2008, 47, 4106; (e) Y.-F. Sheng, Q. Gu, A.-J. Zhang
and S.-L. You, J. Org. Chem., 2009, 74, 6899; (f) Q.-X. Guo, Y.-G.
Peng, J.-W. Zhang, L. Song, Z. Feng and L.-Z. Gong, Org. Lett.,
2009, 11, 4620; (g) Z. Pei, Y. Zheng, J. Nie and J.-A. Ma,
Tetrahetron Lett., 2010, 51, 4658; (h) P. Bachu and T. Akiyama,
Chem. Commun., 2010, 46, 4112; (i) D. Wilcke, E. Herdtweck and
T. Bach, Sylett, 2011, 1235; (j) T. Liang, Z. Zhang and J. C. Antilla,
Angew. Chem. Int. Ed., 2010, 49, 9734; (k) J. Lv, X. Li, L. Zhong, S.
Luo and J.-P. Cheng, Org. Lett., 2010, 12, 1096; (l) L. Yang, Q. Zhu,
S. Guo, B. Qian, C. Xia and H. Huang, Chem. Eur. J., 2010, 16,
1638; (m) J. Lv., L. Zhang, Y. Zhou, Z. Nie, S. Luo and J.-P. Cheng,
Angew. Chem. Int. Ed., 2011, 50, 6610; (n) K. Mori, M. Wakazawa
and T. Akiyama, Chem. Sci., 2014, 5, 1799; (o) S. Saha, S. K.
Alamsetti and S. Schneider, Chem. Commun., 2015, 51, 1461.
(a) M. Zeng, Q. Kang, Q.-L. He and S.-L. You, Adv. Synth. Catal.,
2008, 350, 2169; (b) Q. Kang, X.-J. Zheng and S.-L. You, Chem.
Eur. J., 2008, 14, 3539; (c) Y.-F. Sheng, G.-Q. Li, Q. Kang, A.-J.
Zhang and S.-L. You, Chem. Eur. J., 2009, 15, 3351; (d) C. Zheng,
Y.-F. Sheng, Y.-X. Li and S.-L. You, Tetrahedron 2010, 66, 2875;
(e) M. Zeng, W. Zhang and S. You, Chin. J. Chem. 2012, 30, 2615.
(a) L. Hong, W. Sun, C. Liu, L. Wang, K. Wong and R. Wang, Chem.
Eur. J., 2009, 15, 11105; (b) L. Hong, C. Liu, W. Sun, L. Wang, K.
Wong and R. Wang, Org. Lett., 2009, 11, 2177.
iPr
4d
R = H
4e R = Me
Ph
3d
1d
for 4d, -40 oC: 94%, 96% ee
for 4e, -40 oC to rt: no reaction
Scheme 3. Comparison of the reactivity of 4d and 4e.
Finally, to demonstrate the synthetic utility of our newly
synthesized chiral 2-indole-substituted 1,1-diarylalkanes, 3d and
3l were converted into the corresponding amides 6a and 6b via a
two-step procedure involving oximation of ketone functionality
followed by Beckmann rearrangement (Scheme 4). High overall
yields were obtained for both compounds. More significantly, the
5
10 reactions proceeded uneventfully without compromising the
enantiomeric purities.
6
7
R
R
Me
OMe
Me
OMe
1) NH2OH·HCl, NaOAc
MeOH, reflux, 12 h
N
N
2) TsCl, Et3N
DMAP (cat)
CH2Cl2, rt, 12 h
iPr
iPr
O
O
Ph
NHPh
3d R = H (96% ee)
3l R = Br (97% ee)
6a R = H (76%, 95% ee)
6b R = Br (80%, 96% ee)
8
9
Y. Liu, Z. Cao and H. Du, J. Org. Chem., 2012, 77, 4479.
H. G. Cheng, L. Q. Lu, T. Wang, Q.-Q. Yang, X.-P. Liu, Y. Li, Q.-H.
Deng, J.-R. Chen and W.-J. Xiao, Angew. Chem. Int. Ed., 2013, 52,
3250.
Scheme 4. Further derivatization of the synthesized chiral 2-indole-
substituted 1,1-diarylalkanes
80 10 Y. Zhang, X. Liu, X. Zhao, J. Zhang, L. Zhou, L. Lin and X. Feng,
Chem. Commun., 2013, 49, 11311.
11 B. Bi, Q.-X. Lou, Y.-Y. Ding, S.-W. Chen, S.-S. Zhang, W.-H. Hu
and J.-L. Zhao, Org. Lett., 2015, 17, 540.
15
In conclusion, we have established an organocatalytic protocol
for enantioselective synthesis of 2-indole-substituted 1,1-
diarylalkanes. The new protocol is compatible with a wide variety
of indol-2-yl carbinols and various enamides. Contrary to the
reported methods, our strategy has utilized indole derivatives as
12 (a) T.-H. Fu, A. Bonaparte and S. F. Martin, Tetrahedron Lett., 2009,
85
90
50, 3253; (b) B. A. Granger, I. T. Jewett, J. D. Butler, B. Hua, C. E.
Knezevic, E. I. Parkinson, P. J., Hergenrother and S. F. Martin, J.
Am. Chem. Soc., 2013, 135, 12984.
20 electrophiles, and thereby offering a new method for accessing
chiral 2-indole-substituted 1,1-diarylalkanes. In addition, the
synthetic utility of the chiral compounds was also exemplified.
An investigation of the biological property of chiral 2-indole-
substituted 1,1-diarylalkanes is currently underway.
13 (a) X. Zhong, Y. Li and F.-S. Han, Chem. Eur. J., 2012, 18, 9784; (b)
X. Zhong, Y. Li, J. Zhang, W.-X. Zhang, S.-X., Wang and F.-S. Han,
Chem. Commun., 2014, 50, 11181; (c) S. Qi, C.-Y. Liu, J.-Y. Ding,
F.-S. Han, Chem. Commun., 2014, 50, 8605; (d) X. Zhong, Y. Li, J.
Zhang and F.-S. Han, Org. Lett., 2015, 17. 720.
25
Financial support from NSFC (21272225), and State Key
Laboratory of Fine Chemicals, Dalian University of Technology
(KF 1201) is acknowledged.
14 For selected reviews, see: (a) S.-L. You and Q. Cai, M. Zeng, Chem.
Soc. Rev., 2009, 38, 2190; (b) J. Yu, F. Shi and L. Gong, Acc. Chem.
Res., 2011, 44, 1156; (c) J.-H. Xie, S.-F. Zhou and Q.-L. Zhou,
Chem. Soc. Rev., 2012, 41, 4126; (d) M. Mahlau and B. List, Angew.
Chem. Int. Ed., 2013, 52, 518; (e) K. Brak and E. N. Jacobsen,
Angew. Chem. Int. Ed., 2013, 52, 534; (f) R. J. Phipps, G. L.
Hamilton and F. D. Toste, Nat. Chem., 2013, 4, 603; (g) D. Parmar,
E. Sugiono, S. Raja and M. Rueping, Chem. Rev., 2014, 114, 9047.
15 (a) P. Christ, A. G. Lindsay, S. S. Vormittag, J.-M. Neudörfl, A.
Berkessel and A. C. O’Donoghue, Chem. Eur. J., 2011, 17, 8524; (b)
K. Kaupmees, N. Tolstoluzhsky, S. Raja, M. Rueping and I. Leito,
Angew. Chem. Int. Ed., 2013, 52, 11569.
95
Notes and references
1
For selected reviews, see: (a) M. S. Shchepinov and V. A. Korshun,
Chem. Soc. Rev., 2003, 32, 170; (b) M. Shiri, M. A. Zolfigol, H. G.
Kruger and Z. Tanbakouchian, Chem. Rev., 2010, 110, 2250; for
selected research articles, see: (c) Q. Z. Hu, L. N. Yin, C. Jagusch,
U. E. Hille and R. W. Hartmann, J. Med. Chem., 2010, 53, 5049; (d)
S. Messaoudi, A. Hamze, O. Provot, B. Tréguier, J. Rodrigo De
Losada, J. Bignon, J.-M. Liu, J. Wdzieczak-Bakala, S. Thoret, J.
Dubois, J.-D. Brion and M. Alami, ChemMedChem, 2011, 6, 488; (e)
T. P. Pathak, J. G. Osiak, R. M. Vaden, B. E. Welm and M. S.
Sigman, Tetrahedron, 2012, 68, 5203.
100
30
35
40
105 16 (a) M. Rueping and C. Azap, Angew. Chem. Int. Ed., 2006, 45, 7832;
(b) T. Akiyama, Y. Tamaru, J. Itoh, H. Morita and K. Fuchibe,
Synlett, 2006, 141; (c) M. Rueping, E. Sugiono and F. R. Schoepke,
Synlett, 2007, 1441.
17 CCDC 1404860 contains the supplementary crystallographic data of
2
3
For a recent comprehensive review, see: S. Safe, S. Papineni and S.
Chintharlapalli, Cancer Lett., 2008, 269, 326.
For selected publications, see: (a) T. P. Pathak, K. M. Gligorich, B. E.
Welm and M. S. Sigman, J. Am. Chem. Soc., 2010, 132, 7870; (b) Z.
Wang, F. Ai, Z. Wang, G. Zhu, Z. Lin and J. Sun, J. Am. Chem. Soc.,
2015, 137, 383.
110
N-tosylhydrazone derivative of 3t.
115
45 4
For a recent review, see: A. J. Kochanowska-Karamyan and M. T.
Hamann, Chem. Rev., 2010, 110, 4489.
4
| Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]